These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 29777855

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY, Termsarasab U, Lee MY, Kim DH, Lee SY, Kim JS, Cho HJ, Kim DD.
    Acta Biomater; 2017 Jul 15; 57():262-273. PubMed ID: 28483700
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P, Tan A, Prestidge CA, Nielsen HM, Müllertz A.
    Int J Pharm; 2014 Dec 30; 477(1-2):390-8. PubMed ID: 25455781
    [Abstract] [Full Text] [Related]

  • 46. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
    Golkar N, Samani SM, Tamaddon AM.
    Int J Pharm; 2016 Aug 20; 510(1):30-41. PubMed ID: 27291973
    [Abstract] [Full Text] [Related]

  • 47. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS, Hamdy RC, Tabrizian M.
    Biomaterials; 2008 Mar 20; 29(9):1207-15. PubMed ID: 18076987
    [Abstract] [Full Text] [Related]

  • 48. Design of chitospheres loaded with pristine polymer particles for extended drug delivery via polyelectrolyte complexation and particulate leaching.
    Ramburrun P, Choonara YE, Kumar P, du Toit LC, Pillay V.
    Int J Pharm; 2015 Feb 01; 479(1):189-206. PubMed ID: 25556054
    [Abstract] [Full Text] [Related]

  • 49. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug.
    Zhang X, Wang H, Zhang T, Zhou X, Wu B.
    Eur J Pharm Sci; 2014 Oct 01; 62():301-8. PubMed ID: 24956461
    [Abstract] [Full Text] [Related]

  • 50. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method.
    Lin WJ, Kang WW.
    J Microencapsul; 2003 Oct 01; 20(2):169-77. PubMed ID: 12554372
    [Abstract] [Full Text] [Related]

  • 51. Study on glycolic acid delivery by liposomes and microspheres.
    Perugini P, Genta I, Pavanetto F, Conti B, Scalia S, Baruffini A.
    Int J Pharm; 2000 Feb 25; 196(1):51-61. PubMed ID: 10675707
    [Abstract] [Full Text] [Related]

  • 52. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
    Motiei M, Kashanian S.
    Eur J Pharm Sci; 2017 Mar 01; 99():285-291. PubMed ID: 28057549
    [Abstract] [Full Text] [Related]

  • 53. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.
    Ahad A, Raish M, Ahmad A, Al-Jenoobi FI, Al-Mohizea AM.
    Eur J Pharm Sci; 2018 Jan 01; 111():409-417. PubMed ID: 29030177
    [Abstract] [Full Text] [Related]

  • 54. Preparation, Characterization, and Release Kinetics of Chitosan-Coated Nanoliposomes Encapsulating Curcumin in Simulated Environments.
    Hasan M, Elkhoury K, Kahn CJF, Arab-Tehrany E, Linder M.
    Molecules; 2019 May 27; 24(10):. PubMed ID: 31137865
    [Abstract] [Full Text] [Related]

  • 55. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
    Mohammed M, Mansell H, Shoker A, Wasan KM, Wasan EK.
    Drug Dev Ind Pharm; 2019 Jan 27; 45(1):76-87. PubMed ID: 30169982
    [Abstract] [Full Text] [Related]

  • 56. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
    Peng R, Huang J, He L, Zhao L, Wang C, Wei W, Xia T, Mao Y, Wen Y, Wang L, Yang J.
    Eur J Pharm Sci; 2020 Apr 15; 146():105262. PubMed ID: 32060005
    [Abstract] [Full Text] [Related]

  • 57. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
    Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W.
    Int J Pharm; 2009 Sep 08; 379(1):131-8. PubMed ID: 19559775
    [Abstract] [Full Text] [Related]

  • 58. Microfluidic platform for synthesis and optimization of chitosan-coated magnetic nanoparticles in cisplatin delivery.
    Siavashy S, Soltani M, Ghorbani-Bidkorbeh F, Fallah N, Farnam G, Mortazavi SA, Shirazi FH, Tehrani MHH, Hamedi MH.
    Carbohydr Polym; 2021 Aug 01; 265():118027. PubMed ID: 33966822
    [Abstract] [Full Text] [Related]

  • 59. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K, Sundaresan A, Cheow WS.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt A):427-43. PubMed ID: 23872180
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.